Introduced:
Jun 23, 2025
Policy Area:
Health
Congress.gov:
Bill Statistics
3
Actions
0
Cosponsors
0
Summaries
1
Subjects
1
Text Versions
Yes
Full Text
AI Summary
AI Summary
No AI Summary Available
Click the button above to generate an AI-powered summary of this bill using Claude.
The summary will analyze the bill's key provisions, impact, and implementation details.
Error generating summary
Latest Action
Jun 23, 2025
Referred to the House Committee on Energy and Commerce.
Actions (3)
Referred to the House Committee on Energy and Commerce.
Type: IntroReferral
| Source: House floor actions
| Code: H11100
Jun 23, 2025
Submitted in House
Type: IntroReferral
| Source: Library of Congress
| Code: H11100
Jun 23, 2025
Submitted in House
Type: IntroReferral
| Source: Library of Congress
| Code: 1025
Jun 23, 2025
Subjects (1)
Health
(Policy Area)
Full Bill Text
Length: 2,980 characters
Version: Introduced in House
Version Date: Jun 23, 2025
Last Updated: Nov 13, 2025 6:38 AM
[Congressional Bills 119th Congress]
[From the U.S. Government Publishing Office]
[H. Res. 532 Introduced in House
(IH) ]
<DOC>
119th CONGRESS
1st Session
H. RES. 532
Supporting the designation of ``Brain and Spine Metastasis Awareness
Month''.
_______________________________________________________________________
IN THE HOUSE OF REPRESENTATIVES
June 23, 2025
Mrs. Foushee submitted the following resolution; which was referred to
the Committee on Energy and Commerce
_______________________________________________________________________
RESOLUTION
Supporting the designation of ``Brain and Spine Metastasis Awareness
Month''.
Whereas brain and spine metastasis can occur with almost any type of cancer;
Whereas improved cancer treatments are leading to longer patient survival, but
brain and spine metastasis rates are increasing;
Whereas specific cancers commonly spread to the brain and spine, such as
melanoma, lung, breast, colon, and prostate cancers;
Whereas brain metastases are a leading cause of morbidity and mortality in
patients with cancer;
Whereas brain metastases are five times more common than primary brain tumors;
Whereas advanced treatment options are available to improve patient outcomes;
Whereas disparities in cancer care exist, and awareness is crucial to address
these disparities;
Whereas different treatments are needed for brain and spine metastasis than for
other cancers;
Whereas there are publicly available resources where patients and families can
find information on brain and spine metastasis; and
Whereas new and novel therapies are offering hope, but more support and funding
for clinical trials and specialized centers are necessary: Now,
therefore, be it
Resolved, That the House of Representatives--
(1) supports the designation of ``Brain and Spine
Metastasis Awareness Month'';
(2) recognizes and affirms the commitment by the House of
Representatives to increasing awareness of treatment options
for people with cancer that has spread to the brain or spine;
(3) recognizes and affirms the dedication of the House of
Representatives to increasing education for brain and spine
metastasis so individuals can better understand their cancer or
the cancer of a loved one; and
(4) calls on the Secretary of Health and Human Services
to--
(A) increase education and awareness about
treatment options available for patients with brain and
spine metastases, including advances and improvements
in medical therapies, such as targeted therapies or
immunotherapies;
(B) support resources to establish and support
centers for brain and spine metastasis;
(C) provide resources to increase access to
dedicated clinical trials for patients with brain or
spine metastases; and
(D) invest in research specifically into the
biology and treatment of brain and spine metastasis,
particularly across cancers.
<all>
[From the U.S. Government Publishing Office]
[H. Res. 532 Introduced in House
(IH) ]
<DOC>
119th CONGRESS
1st Session
H. RES. 532
Supporting the designation of ``Brain and Spine Metastasis Awareness
Month''.
_______________________________________________________________________
IN THE HOUSE OF REPRESENTATIVES
June 23, 2025
Mrs. Foushee submitted the following resolution; which was referred to
the Committee on Energy and Commerce
_______________________________________________________________________
RESOLUTION
Supporting the designation of ``Brain and Spine Metastasis Awareness
Month''.
Whereas brain and spine metastasis can occur with almost any type of cancer;
Whereas improved cancer treatments are leading to longer patient survival, but
brain and spine metastasis rates are increasing;
Whereas specific cancers commonly spread to the brain and spine, such as
melanoma, lung, breast, colon, and prostate cancers;
Whereas brain metastases are a leading cause of morbidity and mortality in
patients with cancer;
Whereas brain metastases are five times more common than primary brain tumors;
Whereas advanced treatment options are available to improve patient outcomes;
Whereas disparities in cancer care exist, and awareness is crucial to address
these disparities;
Whereas different treatments are needed for brain and spine metastasis than for
other cancers;
Whereas there are publicly available resources where patients and families can
find information on brain and spine metastasis; and
Whereas new and novel therapies are offering hope, but more support and funding
for clinical trials and specialized centers are necessary: Now,
therefore, be it
Resolved, That the House of Representatives--
(1) supports the designation of ``Brain and Spine
Metastasis Awareness Month'';
(2) recognizes and affirms the commitment by the House of
Representatives to increasing awareness of treatment options
for people with cancer that has spread to the brain or spine;
(3) recognizes and affirms the dedication of the House of
Representatives to increasing education for brain and spine
metastasis so individuals can better understand their cancer or
the cancer of a loved one; and
(4) calls on the Secretary of Health and Human Services
to--
(A) increase education and awareness about
treatment options available for patients with brain and
spine metastases, including advances and improvements
in medical therapies, such as targeted therapies or
immunotherapies;
(B) support resources to establish and support
centers for brain and spine metastasis;
(C) provide resources to increase access to
dedicated clinical trials for patients with brain or
spine metastases; and
(D) invest in research specifically into the
biology and treatment of brain and spine metastasis,
particularly across cancers.
<all>